A New Approach page top left image

Leadership

Governance Group

Our Governance Group is a small steering group with overall responsibility for the direction and progress of the Center, and statutory legal and fiscal responsibilities. Comprised of senior members of the Harvard medical community, the group provides exceptional leadership and vision. 

  • Jeffrey S. Flier, MD
  • Joseph B. Martin, MD, PhD (Co-chair) 
  • Dennis J. Selkoe, MD (Co-chair)
  • Daniel G. Ennis, MBA, MPA
  • Bradley T. Hyman, MD, PhD
  • Adrian J. Ivinson, PhD (Director)


Council

Our Council ensures that the Harvard NeuroDiscovery Center remains true to its mission to support translational and collaborative neuroscience. Its members provide an invaluable combination of business strategy, marketing and communications expertise. 

  • Martha Crowninshield (Co-chair)
  • Robert Kaplan (Co-chair)
  • Richard Cohen
  • Dan Freudenberger
  • Timothy Johnson, MD
  • Robert Pozen
  • Kathleen Rasmussen
  • Arthur Ullian


Office of the Director

The Office of the Director, headed by Adrian J. Ivinson, provides intellectual and administrative leadership, and is responsible for the overall management of the NeuroDiscovery Center and its programs.

  • Adrian J. Ivinson, PhD (Director)
  • Ross Stein, PhD (Director, Laboratory for Drug Discovery in Neurodegeneration)
  • Craig Kennedy, MBA, MPH (Deputy Director)
  • Patti A. Stoll, MBA (Deputy Director)
  • Zara Smith (Programs Manager)
  • Amanda K. Rowley (Administrative Coordinator)
  • Jon Lu (Administrative Assistant)


Scientific Advisory Board

The Scientific Advisory Board advises the Governance Group on scientific priorities and applicability of NeuroDiscovery Center  programs. It is comprised of representatives from across the Harvard medical community with expertise relevant to researching and treating neurodegenerative diseases. Long term members are regularly supplemented by occasional or ad hoc advisors.

  • Dennis Selkoe, MD, Chair (Brigham and Women’s Hospital)
  • Robert Brown, MD, PhD (Massachusetts General Hospital)
  • Constance Cepko, PhD (Harvard Medical School)
  • Thaddeus Dryja, MD (Massachusetts Eye and Ear Infirmary)
  • Dana Gabuzda, PhD (Dana Farber Cancer Institute)
  • Michael Greenberg, PhD (Children’s Hospital)
  • David Hafler, MD (Brigham and Women’s Hospital)
  • Ole Isacson, MD (Director, Medical Science, McLean Hospital)
  • Peter Lansbury, PhD (Brigham and Women’s Hospital)
  • Jeff Macklis, MD (Massachusetts General Hospital)
  • Josh Sanes, PhD (Harvard University)
  • Reisa Sperling, MD (Brigham and Women’s Hospital)
  • Christopher Walsh, MD, PhD (Beth Israel Deaconess Medical Center)
  • Anne Young, MD, PhD (Massachusetts General Hospital)
  • Junying Yuan, PhD (Harvard Medical School)
  • Joseph Martin, MD, PhD (Harvard Medical School, ex officio)
  • Adrian Ivinson, PhD (Harvard NeuroDiscovery Center, ex officio)